Iron Overload and Growth Velocity in Thalassemia and Sickle Cell Anemia
NCT00972231 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 93
Last updated 2015-09-01
Summary
Iron overload impaired growth in Thalassemia patients due to iron deposition in the endocrine glands, including the hypophysis and gonads. The issue of iron overload in Sickle Cell Anemia is recently studied more extensively and preliminary studies shows that endocrine damage is rarer in those patients.
Growth velocity was not systematically studied in patients with Iron Overload, even in thalassemia patients in spite several studies that assess the endocrine function in those patients. In Sickle Cell Patients this issue was not studied.
The purpose of this study is to assess the growth velocity in a cohort of Thalassemia Major and Intermedia patients and compare the results to another group of Sickle Cell patients, including Sickle cell thalassemia.
Conditions
Interventions
- OTHER
-
Medical Chart Summary
Summary of the Medical Files including annual growth velocity, endocrine function and iron overload status.
Sponsors & Collaborators
-
HaEmek Medical Center, Israel
lead OTHER
Principal Investigators
-
Ariel Koren, MD · Pediatric Dpt B and Pediatric Hemaology Unit - Ha'Emek Medical Center - Afula - Israel
-
Carina Levin, MD · Pediatric Hematology Unit, Ha'Emek Medical Center, Afula, Israel
-
Daniela Mathov, Student · Pediatic Hematology Unit, Ha'Emek Medical Center, Afula, Israel
Eligibility
- Min Age
- 5 Years
- Max Age
- 45 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2009-01-31
- Primary Completion
- 2010-12-31
- Completion
- 2010-12-31
Countries
- Israel
Study Locations
More Related Trials
-
Reproductive Capacity and Iron Burden in Thalassemia
NCT02308904 ·Status: COMPLETED ·Phase: NA
-
Endocrine and Nutritional Assessment in B Thalassemia Major
NCT00456690 ·Status: COMPLETED ·Phase: NA
-
Iron Mediated Vascular Disease in Sickle Cell Anemia Patients
NCT01239901 ·Status: COMPLETED
-
Demographic, Clinical, Laboratory and Genetical Characteristics of Patients With Beta Thalassemia Intermedia
NCT01443312 ·Status: COMPLETED
-
Genes Influencing Iron Overload State
NCT01158794 ·Status: COMPLETED
-
"Iron Overload and Endocrinological Diseases"
NCT06137079 ·Status: RECRUITING
-
Iron Status in BTM With Blood Transfusion
NCT04947540 ·Status: UNKNOWN
-
Prevalence Of Microalbuminuria Among Children Suffering From Sickle Cell Nephropathy and Sickle Cell/Beta-Thalassemia
NCT01092169 ·Status: UNKNOWN
-
Evaluating People With Thalassemia: The Thalassemia Longitudinal Cohort (TLC) Study
NCT00661804 ·Status: COMPLETED
-
Efficacy and Safety of Efficacy and Safety of Continued Iron Chelation Therapy In Poly-transfused Thalassemia Patients With Low Serum Ferritin (< 500 ng/ml)
NCT01996683 ·Status: UNKNOWN ·Phase: NA
-
Clinical and Laboratory Characteristics of Sickle Cell Anemia Patients Admitted With Fever
NCT00736060 ·Status: COMPLETED
-
Gonadal Function in Thalassemic Patient
NCT07288762 ·Status: NOT_YET_RECRUITING
-
Assessment of Pain in People With Thalassemia
NCT00872339 ·Status: COMPLETED
-
Demographic, Clinical and Laboratory Characteristics of Children With Alpha Thalassemia in Northern Israel
NCT00971984 ·Status: COMPLETED
-
Multi-Center Study of Iron Overload: Pilot Study
NCT01114776 ·Status: COMPLETED
-
Pharmacotherapy Prescribing Pattern and the Adherence Level to Iron Chelation Therapy in Thalassemia
NCT06210139 ·Status: COMPLETED
-
Sexual Maturation in β-Thalassemia Major Patients in Assiut University Hospital
NCT03847558 ·Status: UNKNOWN
-
NAC Effect on Iron Overload and Blood Transfusion in β-thalassemia Major
NCT05777733 ·Status: UNKNOWN ·Phase: PHASE1
-
MRI Evaluation of Iron Overload in the Heart, Liver and Pancreas in Patients Receiving Multiple Blood Transfusions.
NCT00629291 ·Status: COMPLETED
-
Complications in Children With B- Thalassemia Major
NCT03462784 ·Status: UNKNOWN
-
Growth Evaluation, Health Promotion, and Clinical Management in Children and Adolescents With Thalassemia
NCT06931912 ·Status: RECRUITING ·Phase: NA
-
Intensive Combined Chelation Therapy for Iron-Induced Cardiac Disease in Patients With Thalassemia Major
NCT00800761 ·Status: COMPLETED ·Phase: PHASE4
-
Detection Of β-thalassemia Carriers In Assiut
NCT03822585 ·Status: UNKNOWN ·Phase: NA
-
Renal Function Among Thalassemia Patients Treated by a Oral Chelator Deferasirox
NCT01905774 ·Status: COMPLETED
-
Invasive Infections in Children With Hemoglobinopathies
NCT00456443 ·Status: COMPLETED